Hanne Callewaert
Developing vaccines that address major real-world vaccinology challenges in preventive and therapeutic settings.
Hanne Callewaert
Developing vaccines that address major real-world vaccinology challenges in preventive and therapeutic settings.
CLASS OF 2024
COMPANY
AstriVax NV
Co-Founder & CEO
LOCATION
Heverlee, Belgium
AREA OF FOCUS
Infectious diseases
BIO
Hanne Callewaert has 20+ years of expertise in the life science industry exhibiting a unique capability to merge strategy and operational execution. Global industry experience in large pharmaceutical industry and smaller biotech environment. Co-founder and CEO of AstriVax, being responsible for incubation, start-up and scale-up, financing (VC and non-dilutive), operational and strategic set- up. Strong experience in development of commercial, late or early stage vaccines, monoclonal antibodies, peptides and small molecules. Proven track record to build and lead diverse teams. Innovative mindset, demonstrated ability to think beyond commonly accepted boundaries, understanding well different personalities, able to perform complex tasks and capable to distil the essence from the noise.